- Our Story
- In Memory
Gal Bitan, Ph.D.
Associate Professor, Neurology, Neuroscience IDP, Department of Neurology David Geffen School of Medicine at UCLA
Dr. Bitan’s laboratory focuses on developing new therapeutic and diagnostic tools for diseases related to protein misfolding and aggregation, particularly Alzheimer's and Parkinson's diseases. The laboratory synthesizes novel molecules and explores their potential for diagnostic and therapeutic uses. These efforts are guided by structural knowledge that is obtained though multifaceted, collaborative experimental and theoretical studies. The techniques and methodologies used in the laboratory are interdisciplinary in nature, ranging from peptide chemistry, through biochemistry and biophysics, to molecular, cell, and animal biology.
Dr. Bitan received both his B.S. and Ph.D. from The Hebrew University of Jerusalem, Israel.
Project Description Researchers Funding Molecular Tweezers—Novel Inhibitors of Amyloidogenic Proteins and Promising Drug Candidates for Alzheimer’s Disease
The goal of this project is to plan expanded in vivo characterization of the efficacy of “molecular tweezers” toward development of disease-modifying therapy for AD and related diseases.
Gal Bitan, Ph.D. 2011
These published papers resulted from Cure Alzheimer’s Fund support."Protection of primary neurons and mouse brain from Alzheimer’s pathology by molecular tweezers " , Brain, A Journal of Neurology , doi:10.1093/brain/aws289 , November 26, 2012 , 3735-48,